The CRISPR/Cas9-edited EIF2D polyclonal knockout cell population is a genetically disrupted derivative of the AGS human gastric adenocarcinoma cell line, designed for loss-of-function studies of the translation initiation factor EIF2D. By employing CRISPR/Cas9-mediated gene disruption, this polyclonal population eliminates functional EIF2D expression across a heterogeneous cell pool, enabling investigation of its role in non-canonical translation initiation without clonal selection bias. The product provides a robust tool for examining downstream molecular consequences of EIF2D deficiency in a gastric cancer context.
The parental AGS cell line was established from the gastric adenocarcinoma of a 54-year-old Caucasian female and serves as a widely utilized epithelial model for gastric carcinogenesis. These adherent cells retain key characteristics of gastric cancer, including dysregulated growth signaling and stress response pathways, making them suitable for dissecting mechanisms that drive tumorigenesis, metastasis, and drug resistance. Their use in the present knockout context allows direct interrogation of EIF2D function in a pathophysiologically relevant cellular environment.
EIF2D encodes a translation initiation factor that binds the 40S ribosomal subunit to recruit initiator tRNA in a GTP-independent manner, thereby promoting non-canonical translation of mRNAs with structured 5?? untranslated regions. It operates within a network involving eIF5B and eIF1A, and is responsive to mTORC1-mediated growth signals and cellular stress cues, including those arising from the integrated stress response. Downstream, EIF2D facilitates synthesis of proteins critical for adaptation to endoplasmic reticulum stress and maintenance of proliferative capacity. Its activity is integrated with canonical initiation components such as eIF1, eIF1A, eIF3, eIF5, eIF2, and the 60S subunit.
In AGS gastric cancer cells, EIF2D knockout is anticipated to perturb the translation of specific stress-adaptive and pro-survival proteins, potentially impairing tumor cell growth, migration, and chemosensitivity. By creating a model of EIF2D loss in an adenocarcinoma backdrop, researchers can dissect how dysregulated non-canonical initiation contributes to gastric tumorigenesis and therapy resistance. The polyclonal nature preserves population-level heterogeneity, better mimicking tumor cell diversity and averting artifacts from single-cell bottlenecking.
This polyclonal knockout model supports a range of downstream analyses, including Western blotting to confirm EIF2D depletion, RT-qPCR and RNA-seq for transcriptomic profiling, and polysome fractionation to assess translational shifts. Functional studies such as MTT proliferation assays, scratch wound migration tests, and cisplatin sensitivity evaluations provide insights into phenotypic consequences. Immunofluorescence detection of ribosomal markers enables localization studies. For further technical information, custom services, or bulk ordering, please contact Ascent Research.
